Cutler Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-300
Closed -$20.6K 4265
2023
Q4
$21K Buy
+300
New +$17.3K ﹤0.01% 1963
2023
Q1
Sell
-180
Closed -$9K 5201
2022
Q4
$9K Buy
+180
New +$9.02K ﹤0.01% 2799
2022
Q2
Sell
-1,786
Closed -$101K 6134
2022
Q1
$109K Sell
1,786
-8,800
-83% -$457K 0.01% 1632
2021
Q4
$554K Buy
10,586
+9,513
+887% +$400K 0.04% 697
2021
Q3
$40K Buy
1,073
+473
+79% +$16.4K ﹤0.01% 2708
2021
Q2
$24K Sell
600
-1,080
-64% -$39.9K ﹤0.01% 3151
2021
Q1
$57K Sell
1,680
-400
-19% -$13.9K ﹤0.01% 2257
2020
Q4
$66K Sell
2,080
-3,120
-60% -$82K 0.01% 1814
2020
Q3
$133K Buy
5,200
+2,400
+86% +$54.8K 0.01% 1147
2020
Q2
$71K Buy
2,800
+1,000
+56% +$20.2K 0.01% 1511
2020
Q1
$27K Buy
1,800
+1,300
+260% +$28.2K ﹤0.01% 2116
2019
Q4
$17K Buy
500
+300
+150% +$3.6K ﹤0.01% 2326
2019
Q3
$1K Buy
+200
New +$1.92K ﹤0.01% 3887
2019
Q2
Sell
-3,600
Closed -$46.2K 5379
2019
Q1
$43K Sell
3,600
-5,800
-62% -$74.1K 0.01% 1539
2018
Q4
$107K Buy
9,400
+2,100
+29% +$33.9K 0.01% 987
2018
Q3
$158K Sell
7,300
-3,449
-32% -$72.1K 0.01% 951
2018
Q2
$189K Sell
10,749
-2,350
-18% -$47.7K 0.02% 801
2018
Q1
$275K Buy
13,099
+4,238
+48% +$82.6K 0.03% 653
2017
Q4
$128K Sell
8,861
-27,699
-76% -$428K 0.01% 1232
2017
Q3
$576K Buy
36,560
+18,816
+106% +$276K 0.03% 588
2017
Q2
$220K Sell
17,744
-2,332
-12% -$27K 0.01% 1200
2017
Q1
$326K Buy
20,076
+931
+5% +$13.5K 0.02% 867
2016
Q4
$288K Sell
19,145
-3,434
-15% -$48.5K 0.01% 1044
2016
Q3
$344K Buy
22,579
+12,098
+115% +$489K 0.02% 820
2016
Q2
$406K Buy
10,481
+379
+4% +$13.6K 0.03% 697
2016
Q1
$280K Buy
10,102
+9,628
+2,031% +$321K 0.03% 816
2015
Q4
$25K Buy
+474
New +$23.9K ﹤0.01% 3194

Other funds holding ITCI